Middle East & Africa Opioids Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Product (Immediate Release Short Acting Opioid and Extended Release Long Acting Opioid), Application (Pain Management, Anesthesia, Diarrhea Suppression, Cough Suppression, De-Addiction, and Others), Route of Administration (Oral, Injectable, and Transdermal Patch), and Distribution Channel (Hospital Pharmacies and Retail Pharmacies)

No. of Pages: 84    |    Report Code: BMIRE00031007    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Opioids Market

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Opioids Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Surging Chronic Pain Incidence

4.1.2 Increasing Geriatric Population

4.2 Market Restraints

4.2.1 Increasing Drug Abuse

4.3 Market Opportunities

4.3.1 Strategic Initiatives by Market Players

4.4 Impact of Drivers and Restraints:

5. Opioids Market - Middle East & Africa Analysis

5.1 Middle East & Africa Opioids Market Overview

5.2 Middle East & Africa Opioids Market Revenue (US$ Million), 2020-2030

5.3 Middle East & Africa Opioids Market Forecast Analysis

6. Middle East & Africa Opioids Market Analysis - by Product

6.1 Immediate Release Short Acting Opioid

6.1.1 Overview

6.1.2 Immediate Release Short Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

6.1.2.1 Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

6.2 Extended Release Long-Acting Opioid

6.2.1 Overview

6.2.2 Extended Release Long-Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

6.2.2.1 Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

7. Middle East & Africa Opioids Market Analysis - by Application

7.1 Pain Management

7.1.1 Overview

7.1.2 Pain Management: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Anesthesia

7.2.1 Overview

7.2.2 Anesthesia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Diarrhea Suppression

7.3.1 Overview

7.3.2 Diarrhea Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Cough Suppression

7.4.1 Overview

7.4.2 Cough Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.5 De-Addiction

7.5.1 Overview

7.5.2 De-Addiction: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Opioids Market Analysis - by Route of Administration

8.1 Oral

8.1.1 Overview

8.1.2 Oral: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8.2 Injectable

8.2.1 Overview

8.2.2 Injectable: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Transdermal Patch

8.3.1 Overview

8.3.2 Transdermal Patch: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Opioids Market Analysis - by Distribution Channel

9.1 Hospital Pharmacies

9.1.1 Overview

9.1.2 Hospital Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9.2 Retail Pharmacies

9.2.1 Overview

9.2.2 Retail Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Opioids Market - Country Analysis

10.1 Middle East & Africa

10.1.1 Middle East & Africa: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)

10.1.1.1 Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast Analysis - by Country

10.1.1.2 Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Product

10.1.1.2.2 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.2.3 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid

10.1.1.2.4 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Application

10.1.1.2.5 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Route Of Administration

10.1.1.2.6 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Distribution Channel

10.1.1.3 South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 South Africa: Middle East & Africa Opioids Market Breakdown, by Product

10.1.1.3.2 South Africa: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.3.3 South Africa: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid

10.1.1.3.4 South Africa: Middle East & Africa Opioids Market Breakdown, by Application

10.1.1.3.5 South Africa: Middle East & Africa Opioids Market Breakdown, by Route Of Administration

10.1.1.3.6 South Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel

10.1.1.4 United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Product

10.1.1.4.2 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.4.3 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid

10.1.1.4.4 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Application

10.1.1.4.5 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Route Of Administration

10.1.1.4.6 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Distribution Channel

10.1.1.5 Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Product

10.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid

10.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Application

10.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Route Of Administration

10.1.1.5.6 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Opioids Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Endo International plc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Mallinckrodt Plc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Neuraxpharm Pharmaceuticals SL

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Hikma Pharmaceuticals Plc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Rusan Pharma Ltd

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Teva Pharmaceutical Industries Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

 

 

 

List of Tables

Table 1. Middle East & Africa Opioids Market Segmentation

Table 2. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 4. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 5. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 6. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 7. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 8. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 9. Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country

Table 10. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 11. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 12. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid

Table 13. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 14. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration

Table 15. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 16. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 17. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 18. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid

Table 19. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 20. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration

Table 21. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 22. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 23. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 24. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid

Table 25. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 26. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 27. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 28. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 29. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 30. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid

Table 31. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 32. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration

Table 33. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 34. Recent Organic Growth Strategies in Opioids Market

Table 35. Recent Inorganic Growth Strategies in the Opioids Market

Table 36. Glossary of Terms, Opioids Market

 

List of Figures

Figure 1. Middle East & Africa Opioids Market Segmentation, by Country

Figure 2. Middle East & Africa Opioids Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Middle East & Africa Opioids Market Revenue (US$ Million), 2020-2030

Figure 5. Middle East & Africa Opioids Market Share (%) - by Product (2022 and 2030)

Figure 6. Immediate Release Short Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Extended Release Long-Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Middle East & Africa Opioids Market Share (%) - by Application (2022 and 2030)

Figure 9. Pain Management: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Anesthesia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Diarrhea Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Cough Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. De-Addiction: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Others: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Middle East & Africa Opioids Market Share (%) - by Route of Administration (2022 and 2030)

Figure 16. Oral: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Injectable: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Transdermal Patch: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Middle East & Africa Opioids Market Share (%) - by Distribution Channel (2022 and 2030)

Figure 20. Hospital Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Retail Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Middle East & Africa Opioids Market, by Key Countries, Revenue (2022) (US$ Million)

Figure 23. Middle East & Africa: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 24. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Growth Strategies in Opioids Market

The List of Companies - Middle East & Africa Opioids Market

  1. Neuraxpharm Pharmaceuticals SL
  2. Endo International plc
  3. Hikma Pharmaceuticals Plc
  4. Mallinckrodt Plc
  5. Rusan Pharma Ltd
  6. Teva Pharmaceutical Industries Ltd